Physiogenex will be presenting its innovative obese NASH hamster model at the 6th Obesity and NASH Summit in Boston, MA, USA, Nov. 30th – Dec.1st, 2022. This unique preclinical model will be presented during an oral presentation on Dec. 1st at 11:30am and the...
Physiogenex will be presenting its innovative obese NASH hamster model at the AFDD (AntiFibrotic Drug Development) Summit in Boston, MA, USA, Nov. 10-11th, 2022. This unique preclinical model will be presented during an oral presentation and the poster session on...
Physiogenex will be presenting 2 novel studies in its innovative obese NASH hamster model at the AASLD Liver Meeting in Washington D.C., USA, Nov. 4-8th, 2022. Studies will be presented during the poster session of Saturday November the 5th, posters #2318 and #2490....
Physiogenex will be presenting the effects of clinical benchmarks in its innovative obese NASH hamster model at the Discovery on Target in Boston, MA, USA, Oct 19th – Oct 20th, 2022. Meet our expert Dr François Briand, our Director of Research and Development during...
Physiogenex will be presenting the cardiometabolic benefits of the GLP-1 receptor agonist semaglutide in its innovative obese NASH hamster model at the European Incretin Study Group 2022 meeting in Lausanne, Switzerland (Sept. 29th – Oct 1st). Meet Dr François...
Physiogenex will be exhibiting at booth#D04 and presenting 2 oral abstracts at the EASD 2022 in Stockholm, Sweden Sept. 19-23. The first oral presentation, entitled “Time-restricted feeding and obeticholic acid/semaglutide drug combination have a different...
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish.AcceptRead More
Privacy & Cookies Policy
Privacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
